HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

12th Edition of International Conference on

Neurology and Neurological Disorders

June 22-24, 2026 | Barcelona, Spain

Neurology 2026

Neuroprotective potential of a traditional Uttarakhand plant against lambda-cyhalothrin-induced neural impairment: A pharmacological investigation

Speaker at Neurology and Neurological Disorders 2026 - Mandeep Kumar Arora
DIT University, India
Title : Neuroprotective potential of a traditional Uttarakhand plant against lambda-cyhalothrin-induced neural impairment: A pharmacological investigation

Abstract:

Neurodegenerative disorders are a group of diseases characterized by the progressive loss of structure or function of neurons, including brain cells, leading to impaired movement, cognition, and other neurological functions. Several factors contribute to the progression of neurodegeneration. Compelling evidence indicates that pesticide exposure is associated with an increased risk of neurodegenerative diseases, as many pesticides are identified as neurotoxic. Neurodegeneration was induced by Pyrethroid insecticides, particularly Lambda-Cyhalothrin (LCT) which are extensively used due to their high potency as insecticides and relatively low mammalian toxicity at recommended doses. However, accumulating evidence suggests that LCT exposure induces neurotoxicity through mechanisms involving oxidative stress, mitochondrial dysfunction, neuroinflammation, and neuronal apoptosis. Crude extract of Pyracantha Crenulata was prepared to mitigate the effect of pesticide using cold maceration method. To evaluate the neuroprotective efficacy of PCEA through a combination of behavioural, biochemical, molecular, and histopathological analyses. Behavioural assessments, including locomotor activity, cognitive performance (Morris water maze), and recognition assessment, were conducted to determine functional recovery following PCEA treatment. Biochemical estimations focused on key markers of oxidative stress (Malondialdehyde (MDA), reduced Glutathione (GSH)), cholinergic function (acetylcholinesterase activity), and nitrosative stress (nitric oxide levels). Furthermore, the modulatory effects of PCEA on Neuroinflammatory Cytokines (TNF-α, IL-6) and Neurotrophic Factors (BDNF) were assessed to elucidate its anti-inflammatory and neurorestorative properties. This study represents the first comprehensive investigation into the neuroprotective potential of P. crenulata against LCT-induced neurotoxicity, using acute (6 days; 4 mg/kg, 8 mg/kg) and chronic (28 days; 2 mg/kg) exposure models. Our findings not only establish dose-dependent neurotoxicity thresholds for LCT but also highlight P. crenulata’s ability to mitigate oxidative damage, suppress neuroinflammation, and preserve neuronal architecture.

Biography:

An accomplished academic and researcher with over 20 years of experience, including 15 years in academia and research, along with international industry exposure in the UK and India. He specializes in neuropharmacology, vascular pharmacology, and pharmacovigilance, focusing on oxidative stress, neuroinflammation, and mitochondrial dysfunction in neurological disorders. His credentials include 45+ publications in high-impact journals, 150+ cumulative impact factor, 1500+ citations, h-index of 16, and 21 Indian patents. He has led funded projects, supervised Ph.D. and M. Pharm scholars, and earned prestigious awards including “Teacher of the Year 2021” and the Scientific Excellence Award, demonstrating outstanding leadership and innovation.

Watsapp